MedPath

Screening and Intervention of Postextubation Dysphagia

Not Applicable
Completed
Conditions
Oropharyngeal Dysphagia
Swallowing Disorder
Endotracheal Intubation
Randomized Controlled Trial
Interventions
Behavioral: SOC program
Registration Number
NCT03284892
Lead Sponsor
National Taiwan University Hospital
Brief Summary

This clinical trial aims to test the validity of a two-item swallowing screen and to examine the effects of the Swallowing and Oral-Care (SOC) Program on resumption of oral intake, incidence of penetration and aspiration, and incidence of pneumonia in adult patients who successfully extubated after ≥ 48 hours of endotracheal intubation.

Detailed Description

Endotracheal intubation is life-sustaining, but it may contribute to postextubation dysphagia (PED) increasing the risk of penetration, aspiration, and aspiration pneumonia. Up to 84% of extubated patients had PED and approximately 60% penetrated and aspirated that can lead to aspiration pneumonia. The aims of this three-year, two-stage study are: 1) In the first stage, the investigators develop a two-item swallowing screen involving oral stereognosis and cough reflex test for predicting the resumption of oral intake and feeding-tube dependence by using a diagnostic accuracy study method; 2) In the second stage, the investigators conduct a randomized, open-label, controlled trial design to examine the effect of a once-daily, 7-day SOC Program on resumption of oral intake, incidence of penetration and aspiration, and incidence of pneumonia in adult patients who successfully extubated after ≥ 48 hours of endotracheal intubation.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
145
Inclusion Criteria
  • Patient who is over 20 years old.
  • Patient how has received over 48 hours endotracheal intubation and had been successfully extubated.
Exclusion Criteria
  • Patient who has a history of neuromuscular disease (e.g., parkinsonism or stroke) or head and neck deformities.
  • Patient who has preexisting difficulty swallowing.
  • Patient who has received a tracheostomy.
  • Patient who were unable to follow verbal instructions.
  • Patient who were on contact and droplet precautions (e.g., open tuberculosis)
  • Patient who were receiving continuous noninvasive ventilation after extubation that precluded the delivery of an SOC intervention

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
SOC groupSOC programReceived SOC program addition to usual care
Primary Outcome Measures
NameTimeMethod
Incidence of penetration and aspirationTime points of assessments: within 48 hrs postextubation and at the day 10 postextubation

Measured by the Fiberoptic endoscopic evaluation of swallowing (FEES) with optional and the study participants either opt-in or opt-out for this procedure, given that its invasive-nature procedure.

Resumption of oral feedingPostextubation 7 days

Measured by Functional Oral Intake Scale

Incidence of pneumoniaPostextubation 30 days

Abstracted from electronic medical records, based on the American Thoracic Society/Infectious Diseases Society of America criteria.

Secondary Outcome Measures
NameTimeMethod
Oral health status scoreTime points of assessments: within 48 hours postextubation and at the day 10 postextubation

Measured by the oral Assessment Guide

Incidence of feeding tube dependencyPostextubation 30 days

Abstracted from electronic medical records

Unstimulated salivary flow rate (centimeter/5 minutes)Time points of assessments: within 48 hours postextubation and at the day 10 postextubation

Measured by the whatman 41 test strip

Lip closure and lingual diadochokinetic statusTime points of assessments: within 48 hours postextubation and at the day 10 postextubation

Measured by the Frenchay Dysarthria Assessment

Trial Locations

Locations (1)

National Taiwan University Hospital

🇨🇳

Taipei, Taiwan

© Copyright 2025. All Rights Reserved by MedPath